Published in Proc Natl Acad Sci U S A on September 01, 1984
Immunochemical evidence of cholecystokinin-like peptides in brain. Nature (1976) 2.67
Histochemical demonstration of heavy metals. A revised version of the sulphide silver method suitable for both light and electronmicroscopy. Histochemistry (1981) 2.32
Immunochemical studies on cholecystokinin. II. Distribution and molecular heterogeneity in the central nervous system and small intestine of man and hog. J Biol Chem (1978) 1.99
High-affinity enkephalin-degrading peptidase in brain is increased after morphine. Nature (1978) 1.87
Distinct cholecystokinin receptors in brain and pancreas. Proc Natl Acad Sci U S A (1980) 1.78
Immunochemical studies on cholecystokinin. I. Development of sequence-specific radioimmunoassays for porcine triacontatriapeptide cholecystokinin. J Biol Chem (1978) 1.62
Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous system. Brain Res (1979) 1.49
Interaction between tetraethylthiuram disulfide and the sulfhydryl groups of D-amino acid oxidase and of hemoglobin. J Biol Chem (1966) 1.38
Cholecystokinin octapeptide-like immunoreactivity: histochemical localization in rat brain. Proc Natl Acad Sci U S A (1979) 1.32
Inhibition of dopamine-beta-hydroxylase by disulfiram in vivo. J Pharmacol Exp Ther (1966) 1.29
Immunohistochemical localization of cholecystokinin- and gastrin-like peptides in the brain and hypophysis of the rat. Proc Natl Acad Sci U S A (1980) 1.25
[Histochemistry of heavy metals; the sulfide-silver procedure]. Dtsch Z Gesamte Gerichtl Med (1958) 1.25
Evidence for coexistence of dopamine and CCK in meso-limbic neurones. Nature (1980) 1.24
METABOLISM OF DISULFIRAM AND DIETHYLDITHIOCARBAMATE IN RATS WITH DEMONSTRATION OF AN IN VIVO ETHANOL-INDUCED INHIBITION OF THE GLUCURONIC ACID CONJUGATION OF THE THIOL. Biochem Pharmacol (1965) 1.21
Cholecystokinin receptors in the brain: characterization and distribution. Science (1980) 1.13
The actions of cholecystokinin and related peptides on pyramidal neurones of the mammalian hippocampus. Brain Res (1981) 1.10
Electron microscopical localization of the zinc in hippocampal mossy fibre synapses by a modified sulfide silver procedure. Histochemie (1967) 1.08
Distribution of gastrin and CCK-like peptides in rat brain. An immunocytochemical study. Histochemistry (1979) 1.04
Electron microscopic demonstration of zinc in the hippocampal formation using Timm's sulfide silver technique. J Histochem Cytochem (1969) 0.99
Characterization of antral gastrin cells with region-specific antisera. J Histochem Cytochem (1977) 0.98
Heavy metals in the brain. A light microscope study of the rat with Timm's sulphide silver method. Methodological considerations and cytological and regional staining patterns. Adv Anat Embryol Cell Biol (1973) 0.96
Inhibition of hexokinase by disulfiram and diethyldithiocarbamate. Biochem Pharmacol (1963) 0.93
Peptide immunocytochemistry. Prog Histochem Cytochem (1981) 0.92
Regional distribution of a high-affinity enkephalin-degrading peptidase ('enkephalinase') and effects of lesions suggest localization in the vicinity of opiate receptors in brain. Neurosci Lett (1979) 0.91
Cholecystokinin in hippocampal pathways. J Comp Neurol (1981) 0.90
Localization of cholecystokinin-like immunoreactivity in isolated nerve terminals. Proc Natl Acad Sci U S A (1978) 0.89
Autoradiographic localization of cholecystokinin receptors in rodent brain. J Neurosci (1983) 0.89
Degradation of cholecystokinin-like peptides by a crude rat brain synaptosomal fraction: a study by high pressure liquid chromatography. Regul Pept (1981) 0.87
Opiates and the hippocampus: a review of the functional and morphological evidence. Pharmacol Biochem Behav (1983) 0.86
Specific depletion of immunoreactive growth hormone-releasing factor by monosodium glutamate in rat median eminence. Nature (1984) 0.86
Cholecystokinin. Clin Gastroenterol (1980) 0.85
Effect of diethyldithiocarbamate (DEDTC) on sulphide silver stained boutons. Reversible blocking of Timm's sulphide silver stain for "heavy" metals in DEDTC treated rats (light microscopy). Exp Brain Res (1973) 0.85
Release of cholecystokinin peptides from a synaptosome-enriched fraction of rat cerebral cortex. Life Sci (1979) 0.85
Light microscopical mapping of the hippocampal region, the pyriform cortex and the corticomedial amygdaloid nuclei of the rat with Timm's sulphide silver method. I. Area dentata, hippocampus and subiculum. Z Anat Entwicklungsgesch (1974) 0.84
The distribution of cholecystokinin-like immunoreactive neurons and nerve terminals in the retrohippocampal region in the rat and guinea pig. J Comp Neurol (1982) 0.83
Enkephalin and zinc in the hippocampal mossy fiber System. Brain Res (1981) 0.83
Localization and opiate receptor binding of enkephalin, CCK and ACTH/beta-endorphin in the rat central nervous system. Peptides (1981) 0.83
CCK-containing terminals in the hippocampus are derived from intrinsic neurons: an immunohistochemical and radioimmunological study. Brain Res (1981) 0.82
Subcellular distribution of enkephalin-dipeptidyl carboxypeptidase (enkephalinase) in rat brain. Neuroscience (1981) 0.82
Heavy metal content in subdivisions of the rat hippocampus (zinc, lead and copper). Brain Res (1976) 0.81
Enkephalinase: selective inhibitors and partial characterization. Peptides (1980) 0.80
Newly synthesized cholecystokinin in subcellular fractions of the rat brain. J Neurochem (1981) 0.79
Localization of enkephalin and cholecystokinin immunoreactivities in the perforant path terminal fields of the rat hippocampal formation. Brain Res (1984) 0.78
Comparative immunocytochemical localization of putative opioid ligands in the central nervous system. Histochemistry (1981) 0.78
Comparative localization of enkephalin and cholecystokinin immunoreactivities and heavy metals in the hippocampus. Brain Res (1983) 0.78
Concentration and in vivo synthesis of cholecystokinin in subcortical regions of the rat brain. J Neurochem (1980) 0.77
Inhibition of enkephalin binding to opiate receptors by zinc ions: possible physiological importance in the brain. Acta Pharmacol Toxicol (Copenh) (1982) 0.77
Zinc content in hippocampus and whole brain of normal rats. Brain Res (1974) 0.76
Zinc concentrations in human plasma and in rat plasma and tissues during lithium administration. Acta Pharmacol Toxicol (Copenh) (1981) 0.76
Cholecystokinin turnover in brain. Brain Res (1983) 0.76
Inhibition of growth hormone and prolactin secretion by a serine proteinase inhibitor. Life Sci (1984) 0.76
[New facts on the theoretical basis of the effect of disulfiram. (Antabus)]. Med Welt (1967) 0.76
Inhibition of opiate receptor binding by zinc ions: possible physiological importance in the hippocampus. Peptides (1981) 0.76
Localization of vasoactive intestinal polypeptide (VIP) to central and peripheral neurons. Proc Natl Acad Sci U S A (1976) 2.45
Production and evaluation of antibodies for the radioimmunoassay of gastrin. Scand J Clin Lab Invest (1972) 2.39
Molecular cloning of human gastrin cDNA: evidence for evolution of gastrin by gene duplication. Proc Natl Acad Sci U S A (1983) 2.35
Determination of gastrin in serum. An evaluation of the reliability of a radioimmunoassay. Scand J Gastroenterol (1973) 2.12
Preparation of 125 I-labelled synthetic human gastrin I for radioimmunoanalysis. Scand J Clin Lab Invest (1972) 2.07
[Back pain--time for a little science?]. Ugeskr Laeger (1998) 2.02
[Molecular biology]. Ugeskr Laeger (2000) 2.02
Immunochemical studies on cholecystokinin. II. Distribution and molecular heterogeneity in the central nervous system and small intestine of man and hog. J Biol Chem (1978) 1.99
Gel filtration studies on immunoreactive gastrin in serum from Zollinger-Ellison patients. Gut (1973) 1.97
Pancreatic somatostatinoma. Clinical features and physiological implications. Lancet (1977) 1.81
Ghrelin stimulates gastric emptying and hunger in normal-weight humans. J Clin Endocrinol Metab (2006) 1.81
Increased cardiac BNP expression associated with myocardial ischemia. FASEB J (2003) 1.78
Pancreatic polypeptide - a postulated new hormone: identification of its cellular storage site by light and electron microscopic immunocytochemistry. Diabetologia (1976) 1.74
MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA). Ann Rheum Dis (2008) 1.71
Rat endocrine pancreatic development in relation to two homeobox gene products (Pdx-1 and Nkx 6.1). J Histochem Cytochem (1998) 1.71
Localization of substance P-like immunoreactivity in mouse gut. Histochemistry (1975) 1.71
Somatostatin cell processes as pathways for paracrine secretion. Science (1979) 1.69
Immunoreactive gastrin components in human serum. Gut (1974) 1.65
Vagal, cholinergic regulation of pancreatic polypeptide secretion. J Clin Invest (1978) 1.63
Immunochemical studies on cholecystokinin. I. Development of sequence-specific radioimmunoassays for porcine triacontatriapeptide cholecystokinin. J Biol Chem (1978) 1.62
Pain thresholds and tenderness in neck and head following acute whiplash injury: a prospective study. Cephalalgia (2001) 1.59
Pancreatic-polypeptide response to food in duodenal-ulcer patients before and after vagotomy. Lancet (1976) 1.56
Imaging of sacroiliitis in early seronegative spondylarthropathy. Assessment of abnormalities by MR in comparison with radiography and CT. Acta Radiol (2003) 1.50
Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous system. Brain Res (1979) 1.49
Protein structure of fetal antigen 1 (FA1). A novel circulating human epidermal-growth-factor-like protein expressed in neuroendocrine tumors and its relation to the gene products of dlk and pG2. Eur J Biochem (1994) 1.49
Comparison of dorzolamide and timolol as suppressors of aqueous humor flow in humans. Arch Ophthalmol (1997) 1.48
Prognostic impact of histologic demonstration of chromogranin A and neuron specific enolase in pulmonary adenocarcinoma. Ann Oncol (1991) 1.47
Amyloid in polypeptide hormone-producing tumors. Lab Invest (1977) 1.45
Simultaneous demonstration of multiple antigens by indirect immunofluorescence or immunogold staining. Novel light and electron microscopical double and triple staining method employing primary antibodies from the same species. Histochemistry (1985) 1.45
Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects. Obes Surg (2012) 1.42
Mixed endocrine pancreatic tumors producing several peptide hormones. Am J Pathol (1975) 1.41
Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse. J Cell Biol (1984) 1.40
The Gordon phenomenon induced by the eosinophil cationic protein and eosinophil protein X. J Allergy Clin Immunol (1982) 1.40
Neuropeptides and neural cell adhesion molecule (NCAM) in CSF from patients with ALS. Acta Neurol Scand (1989) 1.39
[On back training in low back pain]. Ugeskr Laeger (1993) 1.39
Cloned cell lines from a transplantable islet cell tumor are heterogeneous and express cholecystokinin in addition to islet hormones. J Cell Biol (1986) 1.39
Expression but incomplete maturation of progastrin in colorectal carcinomas. Gastroenterology (1993) 1.37
Abnormal gastric histology and decreased acid production in cholecystokinin-B/gastrin receptor-deficient mice. Gastroenterology (1997) 1.37
Release of gastrin by epinephrine in man. Gastroenterology (1973) 1.35
Impaired gastric acid secretion in gastrin-deficient mice. Am J Physiol (1998) 1.33
Increased sensitivity in peroxidase immunocytochemistry. A comparative study of a number of peroxidase visualization methods employing a model system. Histochemistry (1986) 1.33
Growth hormone and prolactin stimulate the expression of rat preadipocyte factor-1/delta-like protein in pancreatic islets: molecular cloning and expression pattern during development and growth of the endocrine pancreas. Endocrinology (1997) 1.30
Immunohistochemical localization of a vasodilatory polypeptide (VIP) in cerebrovascular nerves. Brain Res (1976) 1.27
Correlation between serum gastrin concentration and rat stomach histidine decarboxylase activity. J Physiol (1974) 1.27
Distribution and properties of glucagon immunoreactivity in the digestive tract of various mammals: an immunohistochemical and immunochemical study. Histochemistry (1975) 1.27
Potent inhibitory effects of transplantable rat glucagonomas and insulinomas on the respective endogenous islet cells are associated with pancreatic apoptosis. J Clin Invest (1995) 1.26
Evidence for coexistence of dopamine and CCK in meso-limbic neurones. Nature (1980) 1.24
Structure of a human gastrin gene. Proc Natl Acad Sci U S A (1984) 1.23
New consensus features for tyrosine O-sulfation determined by mutational analysis. J Biol Chem (1997) 1.23
Human endothelial cells contain one type of plasminogen activator. FEBS Lett (1984) 1.21
Methotrexate compliance among patients with rheumatoid arthritis: the influence of disease activity, disease duration, and co-morbidity in a 10-year longitudinal study. Scand J Rheumatol (2010) 1.20
Suppression of rat stomach histidine decarboxylase activity by histamine: H2-receptor-mediated feed-back. J Physiol (1977) 1.20
Localisation of gastrins to neuro- and adenohypophysis. Nature (1978) 1.19
Simultaneous ultrastructural demonstration of multiple peptides in endocrine cells by a novel immunocytochemical method. Nature (1979) 1.18
Met- and Leu-enkephalin immunoreactivity in separate neurones. Nature (1979) 1.17
Immunohistochemical localization of human pancreatic polypeptide (HPP) to a population of islet cells. Cell Tissue Res (1975) 1.16
The effect of gastrin on basal- and glucose-stimulated insulin secretion in man. J Clin Invest (1973) 1.16
Chronic tendinopathy tissue pathology, pain mechanisms, and etiology with a special focus on inflammation. Scand J Med Sci Sports (2008) 1.15
Gastrins in tissue. Concentration and component pattern in gastric, duodenal, and jejunal mucosa of normal human subjects and patients with duodenal ulcer. Gastroenterology (1976) 1.15
Ultrastructural localization of a new neuronal peptide (VIP). Histochemistry (1977) 1.15
The homeodomain protein IPF-1/STF-1 is expressed in a subset of islet cells and promotes rat insulin 1 gene expression dependent on an intact E1 helix-loop-helix factor binding site. Biochem J (1995) 1.15
Magnetic resonance imaging of sacroiliitis in early seronegative spondylarthropathy. Abnormalities correlated to clinical and laboratory findings. Rheumatology (Oxford) (2003) 1.14
A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing. Neuroscience (1980) 1.14
Gastrin and colorectal cancer: a never-ending dispute? Gastroenterology (1995) 1.14
Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome. J Physiol Pharmacol (2007) 1.14
Immunocytochemical localization of urokinase-type plasminogen activator in Lewis lung carcinoma. J Cell Biol (1984) 1.13
Evidence for a common evolutionary origin of gastrin and cholecystokinin. Nature (1977) 1.13
Acute myocardial hypoxia increases BNP gene expression. FASEB J (2004) 1.12
Effect of metiamide, a histamine H2-receptor antagonist, on mucosal blood flow and serum gastrin level. Gastroenterology (1974) 1.12
Eosinophil activation in ulcerative colitis: studies on mucosal release and localization of eosinophil granule constituents. Dig Dis Sci (1998) 1.12
Effects of antrectomy or porta-caval shunting on the histamine-storing endocrine-like cells in oxyntic mucosa of rat stomach. A fluorescence histochemical, electron microscopic and chemical study. J Physiol (1976) 1.12
Pancreatic vein catheterization with gastrin assay in normal patients and in patients with the Zollinger-Ellison syndrome. Am J Surg (1977) 1.12
Heptadecapeptide gastrin in the vagal nerve. Proc Natl Acad Sci U S A (1977) 1.11
Ultrasonography as a tool for diagnosis, guidance of local steroid injection and, together with pressure algometry, monitoring of the treatment of athletes with chronic jumper's knee and Achilles tendinitis: a randomized, double-blind, placebo-controlled study. Scand J Rheumatol (2004) 1.10
Pancreatic gastrin in foetal and neonatal rats. Nature (1976) 1.10
Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass. Int J Obes (Lond) (2013) 1.10
Radioimmunoassay of cholecystokinin in human plasma. Clin Chim Acta (1981) 1.09
Hereditary spastic paraplegia with cerebellar ataxia: a complex phenotype associated with a new SPG4 gene mutation. Eur J Neurol (2004) 1.09
Vasoactive intestinal polypeptide occurs in nerves of the female genitourinary tract. Science (1977) 1.09
Pancreatic function in CCK-deficient mice: adaptation to dietary protein does not require CCK. Am J Physiol (1999) 1.08
Disturbed islet-cell function related to endogenous gastrin release. Studies on insulin secretion and glucose tolerance in pernicious anemia. J Clin Invest (1976) 1.08
Four basic characteristics of the gastrin-cholecystokinin system. Am J Physiol (1981) 1.07
Prevalence of diabetic retinopathy in children and adolescents with IDDM. A population-based multicentre study. Diabetologia (1997) 1.06
Gastrin response to insulin after selective, highly selective, and truncal vagotomy. Gastroenterology (1974) 1.06
Neural regulation of pancreatic hormone secretion by the C-terminal tetrapeptide of CCK. Nature (1980) 1.05
Gastrins in serum. A review of gastrin radioimmunoanalysis and the discovery of gastrin heterogeneity in serum. Scand J Gastroenterol (1973) 1.04